The Vitality Mammography Messaging Study (VMS)

February 6, 2025 updated by: Wits Health Consortium (Pty) Ltd

The Vitality Mammography Study - Testing the Effectiveness of a Booking Platform on Receipt of Screening Mammography - a Randomized Controlled Trial.

The investigators will be conducting a randomized controlled trial amongst members of a Wellness Program to test receipt of mammogram using the Whatsapp social media platform and testing various messages.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The investigators will be conducting a randomised control trial to test the efficacy of WhatsApp messages to increase receipt of mammography amongst eligible women who are members of the Vitality health promotion programme and are also on the Discovery Health Medical Scheme. The study will test a message that 1) has a link to a platform created by the Radiology Society of South Africa which allow members to select a range of practices to book a mammogram, against 2) a message that gives names and telephone numbers of Radiology practices in a 5 km radius of the members home address, against 3) a group with a link to an online platform as well as telephone numbers of radiology practices, against 4) a group where a standard message reminding to go for mammogram will be sent, but without names and telephone numbers of the radiology practices, against 5) a control group where no messages relating to mammography will be sent.

Study Type

Interventional

Enrollment (Actual)

7655

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • South Africa
    • Gauteng
      • Johannesburg, Gauteng, South Africa
        • University of Witwatersrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Females aged 50 to 75 years, who are members of the Discovery Health Medical Plan and who are also members of Vitality and who have not had a screening mammogram in the preceding three years and who have not previously been diagnosed with breast cancer.

Exclusion Criteria:

  • CPA Blocks
  • If member's address location, based on their Discovery profile, was further than 5km radius to the Radiologist practice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Standard message
standard message reminder to screen for breast cancer.
Behavioral: Standard message
Participants will receive standard messaging based on the Cancer Association of South Africa (CANSA) recommendation on breast cancer screening and a reminder to screen for breast cancer.
Experimental: Radiology Booking Site Link
Message with an online link to a radiology practice booking site.
Behavioral: Radiology booking site link.
Participants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site.
Experimental: Radiology practice telephone numbers
Message with a list and telephone numbers of radiology practices.
Behavioral: Radiology practice telephone numbers
Participants will receive a reminder to screen for breast cancer together with a list and telephone numbers of radiology practices
No Intervention: Control - no message
Participants will not receive any messaging regarding mammography.
Experimental: Radiology booking site link and telephone numbers.
Message with a direct online link to a radiology practice booking site and telephone numbers of radiology practices.
Behavioral: Radiology site link and telephone numbers
Participants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site and a list and telephone numbers of radiology practices

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of mammography screening rates using WhatsApp
Time Frame: Five months
Comparison of mammography screening rates using an online radiology booking platform, a message with a radiology practice number, to a standard message, all delivered by WhatsApp.
Five months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Wits Health Consortium (Pty) Ltd

Collaborators

Discovery Vitality

Investigators

  • Principal Investigator: Adele Walker, Discovery

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 27, 2023

Primary Completion (Actual)

February 29, 2024

Study Completion (Actual)

March 31, 2024

Study Registration Dates

First Submitted

October 27, 2023

First Submitted That Met QC Criteria

February 17, 2024

First Posted (Actual)

February 26, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 6, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • M230742

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymized data will be shared with Wits collaborators

IPD Sharing Time Frame

February 2024 and data will be available until February 2025

IPD Sharing Access Criteria

Only select individuals will have access to the data. Data will be password protected.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer Female

Clinical Trials on Standard message

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe